John Konsin of Prapela
A 2x CEO, John is the principal founder and CEO of Prapela, Inc.; a company introducing new technology to help newborns breathe, relax and sleep. John previously held leadership and executive positions at four different Fortune 200 companies and one FTSE 100 company. He has led or assisted in the generation of more than $5.4 billion in revenue and launched over 100 new products. John’s experience includes work in the medical device, diagnostic, medical imaging, durable medical equipment, biologics, wearables, genetic testing, hospital supplies, and consumer products markets. For over 35 years, he has worked closely with Physicians and leaders in Pediatrics, Sports Medicine, Orthopedics, Pain Management, Ob/GYN, and Cardiology. John started his career as a marketing analyst, which led to additional roles in business development, sales, operations, product development, and ultimately to general management. More recently, John is the principal investigator on an NIH/NIDA SBIR research project into neonatal abstinence syndrome and is speaking at events and in Grand Rounds on our opioid epidemic and its impact on opioid-exposed newborns. John holds a B.S. in Business Administration from Duquesne University and an MBA from the University of Colorado.